3rd Targeted Radiopharmaceuticals (TRP) Summit

Kongressthemen
The 3rd Targeted Radiopharmaceuticals (TRP) Summit returns at a crucial time for the entire industry. Spurred on by positive Phase III VISION trial data, there has been huge research investment, on both sides of the Atlantic, on how to deliver radiation therapy directly and specifically to tumours.

Kongressorganizer (PCO)
Hanson Wade

https://go.evvnt.com/852714-1?pid=4832

Herr George McNamara